Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
Shares in Lloyds Banking Group have surged over 18% in three months, reigniting investor interest. As the stock hovers near analyst targets, a key question emerges: does the UK banking giant still offer value, or has the market run ahead of itself?
DoubleVerify's nomination for a Digiday award spotlights its News Accelerator initiative, a strategic push to bolster quality journalism and advertiser confidence in digital news environments. The move comes as the industry grapples with brand safety and seeks more transparent ad placements.
Paramount Skydance is launching a new programmatic advertising platform for live sports on Paramount+ and initiating a quarterly dividend, signaling a strategic shift towards monetizing its existing audience amid ongoing financial pressures.
Arctic policy expert Alice Rogoff contends that U.S. strategic focus and resources should shift to fortifying Alaska's defenses rather than pursuing acquisition of Greenland, citing Alaska's superior positioning against potential missile threats.
As XRP enters a historically weak month, conflicting signals from whale accumulation, ETF flows, and exchange deposits set the stage for a volatile February 2026. Analysts pinpoint key levels that will determine the token's near-term trajectory.
Despite a sharp pullback following gold's price dip, analysts remain bullish on SSR Mining, citing strong earnings potential and attractive valuation metrics even after its stellar run.
Three years after securing $1.3 billion in state incentives, Volkswagen-backed Scout Motors' planned electric vehicle factory faces mounting public costs amid wetland mitigation and inflation, raising questions about risk allocation.
Despite posting quarterly results that beat analyst expectations, KLA Corporation's stock plunged Friday as investors focused on management warnings about component shortages, tariff impacts, and operational constraints.
Yemen's Houthi rebels have seized telecommunications equipment and vehicles from multiple UN offices in Sana'a, the United Nations reported Friday, marking a significant escalation in restrictions that threatens to cripple humanitarian operations in the war-torn country.
U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.
The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
While Tesla's Fremont facility will produce the upcoming Optimus 3, CEO Elon Musk reveals that the subsequent, higher-volume Optimus 4 generation will be manufactured at Gigafactory Texas, marking a strategic pivot in the company's automation roadmap.
A new analysis from the New York Independent System Operator (NYISO) links volatile natural gas markets directly to rising consumer electricity costs. With gas fueling half of New York's power generation, increased demand and export levels are set to keep pressure on household budgets.
Stockholders of CSG Systems International have overwhelmingly approved a slate of key proposals, including governance changes and merger-related actions, during a recent virtual Extraordinary General Meeting. The approvals pave the way for the company's next phase of strategic growth.
Florida-based Seacoast Banking Corporation (SBCF) capped off 2025 with robust loan growth and margin expansion, fueled by its recent acquisition of Villages Bancorporation. Management outlined confident guidance for the coming year, forecasting significant earnings per share growth and improved returns.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
John B. Sanfilippo & Son posts record revenue and a 32% jump in EPS for fiscal Q2 2026, even as higher nut costs and shifting consumer habits pressure sales volumes. The snack nut processor eyes future growth through operational efficiency and new bar production capacity.
The United States has sanctioned Iran's Interior Minister and a prominent businessman, accusing them of human rights abuses and money laundering, as Washington intensifies pressure on Tehran amid ongoing regional tensions.
After two challenging years, Flagstar Bancorp (NYSE: FBC) reported a return to profitability in the fourth quarter of 2025, posting adjusted net income of $30 million. Executives outlined a strategic shift towards commercial lending and a strengthened balance sheet as key drivers for future performance.
